This Bull Bets on 533% Upside Potential for Advaxis, Inc. (ADXS) Shares

Cantor’s Mara Goldstein acknowledges shares have hit some challenges in the latest months, but believes ultimately the company’s programs carry “undiminished” value.

Barclays Bumps Up Price Target on Advaxis, Inc. (ADXS) in the Wake of Amgen Deal

Barclays analyst Jonathan Eckard has boosted the price target for shares of Advaxis, Inc. (NASDAQ:ADXS), from $15 to $20, while reiterating a Buy …

Advaxis: Positive GOG Phase 2 Interim Data Provides Validation For ADXS-HPV, Says H.C. Wainwright

In a research report sent to investors, H.C.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts